ARTICLE
|
doi:10.20944/preprints202301.0131.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
BCG; bladder cancer; non-muscle-invasive bladder cancer; prospective validation; pT1 high-grade bladder cancer; risk stratification; ROL; substaging; TURBT; urothelial carcinoma.
Online: 9 January 2023 (01:17:29 CET)